Metraipolis › archive › dc_73edf9350d2c
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study — Europe PMC PMID:42160591
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42160591
- DOI
- 10.2337/dc25-2973
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T18:14:50.617Z
- SHA-256 of the archived text
177b905cd31646bab945316f41d0a44fbfb2433d2cb521efbf357d93ddff9692- Stable URL of this page
https://metraipolis.com/documento/dc_73edf9350d2c
How to cite
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study — Europe PMC PMID:42160591 — Europe PMC (en), https://europepmc.org/article/MED/42160591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73edf9350d2c (Metraipolis archive dc_73edf9350d2c, sha256 177b905cd31646bab945316f41d0a44fbfb2433d2cb521efbf357d93ddff9692)
BibTeX
@misc{dc73edf9350d2c,
title = {Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study — Europe PMC PMID:42160591},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42160591},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73edf9350d2c; sha256 177b905cd31646bab945316f41d0a44fbfb2433d2cb521efbf357d93ddff9692},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42160591. Agents can read the archived copy with the MCP tool read_document.